The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
NCT Number: NCT05648942
Reducing the occurrence of anemia (low circulating hemoglobin levels) post-surgery has been associated with improved outcome, as it reduces complications and allows for faster return to pre-operative function. Post-operative hemoglobin level is dependent upon its pre-operative value (for a given amount of blood loss). About 17% of patients at the Ottawa Hospital (TOH), will be anemic pre-operatively, and if left untreated the patients will have significantly inferior outcomes compared to non-anemic patients. In order to improve outcomes, when a patient is identified as anemic, typically at the pre-operative assessment clinic, he/she is invited to be reviewed and optimized at the Pre-operative Blood Optimization Clinic (PBOC). However, only a quarter of anemic patients are seen in the PBOC due to the lack of time available between anemia identification and surgery and the current resources available. This project will focus on hemoglobin level optimization of pre-operative hip and knee, primary, arthroplasty patients to demonstrate whether early assessment and treatment of pre-operative anemia can be successfully integrated into practice and its impact on post-operative outcomes. Patients will be randomly assigned to either the current standard of care pathway with an anemia test at the pre-operative assessment clinic (2-4 weeks before surgery), at which time they have the option to seek treatment. Patients who are randomly selected to be in the experimental group, will undergo a test to detect anemia at the time they consent for surgery, which is usually 4-6 months prior to surgery. Patients with anemia, will be invited for treatment at the blood optimization clinic at this time. In doing so, this project will test whether timely identification and simple measures is feasible and whether such practice can reduce the overall anemia burden and ultimately improve patient outcome.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ottawa, Ontario, K1H 8L6, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will undergo a point of care test to identify possible anemia
Time frame: Two years
Number of participants enrolled and willingness of participants to be randomized Comparing the Number of patients screened compared to the number of patients meeting eligibility criteria.
Tracking crossover between the treatment groups, participant retention, and follow-up rates.
Time frame: Two years
Rates of participant follow-up
Time frame: two years
Number of participants who complete treatment in the experimental arm
Time frame: two years
Number of control patients who begin treatment for anemia through family physician or self-medication
Time frame: two years
Hemoglobin levels of both groups at the time of arthroplasty as measured at the pre-operative assessment clinic
Time frame: two years
Change in hemoglobin level in the experimental arm between first formal assessment and pre-operative assessment clinic
Time frame: two years
Prevalence of anemia at the time of arthroplasty procedure
Ottawa Hospital Research Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07380022
Anemia, Autoimmune Diseases
Trikala, Thessaly, Greece
View Trial DetailsNCT07798544
Anemia, Hematologic Diseases
Ioannina, Epirus, Greece
View Trial DetailsNCT07790692
Anemia, Cancer
Taichung, Taiping District, Taiwan
View Trial DetailsNCT07786168
Anemia, Chronic Disease
Lahore, Pakistan
View Trial Details